You are already at the latest version Congestion is the main driver of symptoms, hospitalization, and adverse outcomes in heart failure (HF), yet its clinical assessment remains suboptimal. Traditional ap-proaches, largely focused on estimating intravascular volume through clinical exami-nation, biomarkers, or inferior vena cava assessment, fail to capture the complexity of venous congestion and its impact on organ function.